Pro Dex (PDEX) Return on Capital Employed (2011 - 2026)
Pro Dex (PDEX) posted Return on Capital Employed of 20.02% for Q1 2026, down 9.93% sequentially from 22.23% in Q4 2025, and down 656.0% YoY from 3.6% in Q1 2025.
Pro Dex (PDEX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Pro Dex has reported Return on Capital Employed for 11 years, with the latest figure at 20.02% in Q1 2026.
- Quarterly Return on Capital Employed fell 656.0% year-over-year to 20.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.02% (down 656.0% YoY) and the FY2025 annual result came in at 25.33%, up 705.0% from the prior year.
- Return on Capital Employed slipped to 20.02% in Q1 2026 per PDEX's latest filing, from 22.23% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 26.58% in Q1 2025 and troughed at 10.95% in Q4 2022.
- A 5-year average of 17.69% and a median of 15.86% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed soared 1072 bps in 2025, then tumbled 656 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 10.95% in 2022, then surged by 42 bps to 15.51% in 2023, then surged by 65 bps to 25.54% in 2024, then declined by 13 bps to 22.23% in 2025, then retreated by 10 bps to 20.02% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 20.02%, 22.23%, and 21.95% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Pro Dex | 209.47 Mn | 198.49 Mn | 6.13 Mn | 20.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.02% |
| Dec 31, 2025 | 22.23% |
| Sep 30, 2025 | 21.95% |
| Jun 30, 2025 | 22.22% |
| Mar 31, 2025 | 26.58% |
| Dec 31, 2024 | 25.54% |
| Sep 30, 2024 | 19.84% |
| Jun 30, 2024 | 18.58% |
| Mar 31, 2024 | 15.86% |
| Dec 31, 2023 | 15.51% |
| Sep 30, 2023 | 15.66% |
| Jun 30, 2023 | 13.69% |
| Mar 31, 2023 | 12.81% |
| Dec 31, 2022 | 10.95% |
| Sep 30, 2022 | 12.58% |
| Jun 30, 2022 | 14.31% |
| Mar 31, 2022 | 12.40% |
| Dec 31, 2021 | 14.46% |
| Sep 30, 2021 | 12.13% |
| Jun 30, 2021 | 12.78% |